Avicanna Inc.

C$0.10As of Sun 8 Nov 2026, 12:00 UTC
TSX:AVCNHealthcare
Country Canada
PE (Fwd) •••
TSR 7Y CAGR (41.06%)
Div yield —
ROE (30.04%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.35
PE TTM —
TSR TTM (61.11%)
Mkt cap C$14.46M
ROIC (17.69%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.133
26.21%
12.75%
Hold 5|10|5|10|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
25.36%
30.20%
23.18%
15.49%
Revenue$M
1.479
1.483
1.447
1.444
3.29%
1.57%
1.25%
2.99%
Peers (US$10.24M)
Cap (US$)
PE
8.604M
—
Capital
TTM
5Y
10Y
Leveragex
0.838
—
—
EBIT/Intx
0.934
1.232
1.127
Own earn%
(16.55)
(39.20)
(41.65)
Sh yield%
19.66
25.06
22.90
Owners
Insiders/Inst%
9.44
34.27
Short interest%
0.94
SBC / revenue%
1.82
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
22–29
$1 testx
—
Incr. ROIC%
40